Medical expert of the article
New publications
Preparations
Rapitus
Last reviewed: 23.04.2024
All iLive content is medically reviewed or fact checked to ensure as much factual accuracy as possible.
We have strict sourcing guidelines and only link to reputable media sites, academic research institutions and, whenever possible, medically peer reviewed studies. Note that the numbers in parentheses ([1], [2], etc.) are clickable links to these studies.
If you feel that any of our content is inaccurate, out-of-date, or otherwise questionable, please select it and press Ctrl + Enter.
Rapitus is a medicine that inhibits cough reflex. It is not included in the category of combined drugs, which contain ekspedoranty.
[1]
Indications of the rapita
It is shown in the treatment of a non-productive cough of dry type (against a background of tracheitis with pharyngitis, as well as influenza, laryngitis, pulmonary emphysema and tracheobronchitis with bronchial asthma, besides pathologies inside the respiratory system (infectious or inflammatory or allergic) tumors and obstructive bronchitis of a chronic type).
[2]
Release form
The release is carried out in the form of a syrup, in bottles with a volume of 120 ml. Inside one pack of medicine contains 1 bottle complete with a measuring lid.
Pharmacodynamics
Levodropropizin - from cough drug, which has mainly a peripheral effect, which allows it to reduce the intensity and frequency of coughing attacks and have a bronchodilator effect. The drug differs from other antitussive drugs in that it does not cause dependence or development of tolerance. The impact on the central nervous system is significantly weaker than that of the substance dropropizin.
The effectiveness of the active component is associated with the inhibition of the sensitivity of the conductors within the bronchial tree. The properties of the drug are determined during clinical trials - its effectiveness exceeds the indicator of 90%.
The substance levodropropizin affects the body at the level of nerve conductors, slowing the transmission of nerve impulses inside the C-fibers. Oppresses the release of neuropeptides (among them the substance P and others), and along with this histamine, as a result of which it is possible to obtain a significant bronchodilator effect.
Pharmacokinetics
Ledvropropizin undergoes rapid absorption within the digestive system, reaching a peak of plasma parameters 1.5-2 hours after ingestion. The half-life is approximately 4-5 hours.
[3]
Dosing and administration
The medicine must be taken orally. The procedure is recommended to be performed 1 hour before meals or 2 hours after eating.
For adolescents from 12 years and adults, the dosage is 10 ml (equivalent to 60 mg levorropropizina) three times a day at intervals of at least 6 hours.
For children 2-12 years of age, the dosages are 1 mg / kg three times a day (the total daily dose is 3 mg / kg). Approximate size of recommended dosages:
- for children with a weight within 10-20 kg - 3 ml not more than 3 times a day;
- for children with weight within 20-30 kg - 5 ml not more than 3 methods per day.
The duration of the course is selected by the attending doctor, but in general the therapy can not last more than 1 week. If there is no result after 4-5 days of treatment, it is necessary to stop therapy and consult the doctor.
Use of the rapita during pregnancy
Information on the safety of Rapitus use in pregnant women or during lactation is not available. As a consequence, it is forbidden to appoint him in such cases.
Contraindications
Among the main contraindications:
- the presence of intolerance to levorropropysin or other components of the drug;
- presence of sputum or excessive secretion;
- weakening of mucociliary function (presence of ciliary dyskinesia or Kartagener's syndrome);
- functional renal / hepatic disorders in severe degree;
- Children's age is less than 2 years.
Side effects of the rapita
Because of the medication, certain side effects can develop:
- reactions of the digestive tract: the occurrence of vomiting, heartburn, diarrhea, nausea, dyspeptic phenomena, abdominal pain, and in addition a discomfort sensation in the stomach;
- manifestations from the NA: the development of asthenia, paresthesias, headaches, a feeling of drowsiness or fatigue, as well as dizziness, fainting and frustration;
- reactions from the CCC: the occurrence of cardiopathy or tachycardia, as well as palpitation;
- subcutaneous layer with skin: itching and rash on the skin.
In the case of hypersensitivity to the elements of the drug (amongst such, the dye Ponceau 4R), allergy manifestations may occur.
[4]
Overdose
Signs of an overdose are: sensation of drowsiness, vomiting, frustration, tachycardia and nausea (or symptoms of other side effects may be worse).
The medicine does not have a specific antidote. It is required to conduct gastric lavage and give the patient sorbents. Plasma-substituting solutions should also be administered parenterally.
[7]
Storage conditions
Rapita should be kept in a place inaccessible to young children. The temperature level is not more than 25 ° С.
[10]
Shelf life
Rapitus is suitable for use no more than 2 years since the release of the syrup.
Attention!
To simplify the perception of information, this instruction for use of the drug "Rapitus" translated and presented in a special form on the basis of the official instructions for medical use of the drug. Before use read the annotation that came directly to medicines.
Description provided for informational purposes and is not a guide to self-healing. The need for this drug, the purpose of the treatment regimen, methods and dose of the drug is determined solely by the attending physician. Self-medication is dangerous for your health.